Compare Novavax Inc (NVAX) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Victoria's Secret & Co — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Victoria's Secret & Co trades at $87.75 (market cap $6.95B). The key difference: Victoria's Secret & Co is far larger — about 5.3× Novavax Inc's market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | VSXY | |
|---|---|---|
Market Cap | $1.30B | $6.95B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $88.50 |
52-Week Low | $6.22 | $18.72 |
Enterprise Value | $800.50M | $9.59B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
